Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).
about
Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylasesIdentification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virionHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchThe β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion MechanismsHIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partnerStructure and functional interactions of the Tsg101 UEV domain.Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayThe HIVToolbox 2 web system integrates sequence, structure, function and mutation analysisThe inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.Viral late domainsMolecular characterization of the HIV-1 gag nucleocapsid gene associated with vertical transmission.Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon.HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein.The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.HIV-1 Vpr-a still "enigmatic multitasker".Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx.Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo.Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.Identification of interaction between HIV-1 glycoprotein 41 and integrase.The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells.Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging.Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression.Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism.Solution structure of the human immunodeficiency virus type 1 p6 protein.Alpha-helicoidal HEAT-like Repeat Proteins (αRep) Selected as Interactors of HIV-1 Nucleocapsid Negatively Interfere with Viral Genome Packaging and Virus Maturation.
P2860
Q24530147-BD7D959C-112F-4BD1-B0E9-EB5829C30888Q24797248-B8565FEE-7387-4EC2-BF53-E1C9D418D6A1Q26746070-ABBBE2FC-AE4B-47EC-A826-9FBE71CBFACBQ26747003-328845E5-A4BA-4BDE-9EA9-9E284160B749Q27302871-2B9A6503-CA29-4E14-89EF-05DFE4CB2DDCQ27638973-A70ACA7F-01E0-49C1-8DF7-2BDF8DABF845Q28477791-3F7AC653-75D5-4FA7-A1D5-AEA748C0CDE3Q28539260-CEA252A2-A982-4BB6-A2AA-724313091427Q30440445-95EB5E37-B3EB-4EDE-B8AF-E001B1B92E65Q30671100-691D2BA9-55FA-431A-8E23-AC392CEAF926Q33710135-66D273EC-5002-4E46-A62B-2EDE51DD4541Q34338672-14CA8748-FEFF-48DB-97E8-7334D8166580Q34599516-376EC48F-9905-42B9-BF11-EC433C2C78EFQ34614167-E6DDEA82-2E91-4081-9643-FCB697322224Q34758051-57AD5C93-AF6F-41F5-AD9C-677866F58BBAQ35089155-C5D8CDC2-6A6B-4CF8-A6EC-A98857AFFF2DQ36323002-2E5D06DD-77E7-4ED3-96DA-B9F93D3F9137Q37492757-E80459F8-C8E8-48F5-B794-6D59B5A4D5B0Q37689513-1B55F2AD-BDB9-4CBD-B89F-82C61651B96CQ38348781-6733AD65-3F7E-4CC4-87B2-175A72620F6CQ39565551-0802CB0B-95B6-4B76-9E80-23C91DE3DEE3Q39696115-1CD91095-FE37-467F-AA08-F6E7437D39F5Q40524475-75C82977-AEBF-47E4-B34A-F94BEFF668C1Q40663632-6048D71E-1930-44CD-BF1B-5CAE86F42D18Q43132065-921F47A6-23D3-445F-B149-4820B6E24F1EQ44526080-517249C2-BCDC-42F3-9A66-715EBA134AA4Q44526083-E0B350DF-20F0-4C7F-A626-62B467DCD853Q44981187-87FC66CA-D85A-4FE7-944A-F84AAFA52A8EQ45324180-5EBA1021-0588-42F5-B9B5-5D1EF4EBBD73
P2860
Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Biochemical analyses of the in ...... ciency virus type 1 Vpr and p6
@nl
Biochemical analyses of the in ...... virus type 1 Vpr and p6(Gag).
@en
type
label
Biochemical analyses of the in ...... ciency virus type 1 Vpr and p6
@nl
Biochemical analyses of the in ...... virus type 1 Vpr and p6(Gag).
@en
prefLabel
Biochemical analyses of the in ...... ciency virus type 1 Vpr and p6
@nl
Biochemical analyses of the in ...... virus type 1 Vpr and p6(Gag).
@en
P2093
P2860
P1433
P1476
Biochemical analyses of the in ...... virus type 1 Vpr and p6(Gag).
@en
P2093
D G Myszka
O Pornillos
W I Sundquist
P2860
P304
10537-10542
P356
10.1128/JVI.75.21.10537-10542.2001
P407
P577
2001-11-01T00:00:00Z